{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:58:01Z","timestamp":1772827081640,"version":"3.50.1"},"reference-count":38,"publisher":"e-Century Publishing Corporation","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/asrb7620","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T05:43:10Z","timestamp":1746510190000},"page":"1759-1776","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic value, biological role, and mechanisms of LCN2 in childhood acute lymphoblastic leukemia"],"prefix":"10.62347","volume":"15","author":[{"given":"Xue","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute lymphoblastic leukaemia","volume":"395","author":"Malard","year":"2020","unstructured":"Malard F and Mohty M. Acute lymphoblastic leukaemia. Lancet 2020; 395: 1146-1162.","journal-title":"Lancet"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Rogne T, Wang R, Wang P, Deziel NC, Metayer C, Wiemels JL, Chen K, Warren JL and Ma X. High ambient temperature in pregnancy and risk of childhood acute lymphoblastic leukaemia: an observational study. Lancet Planet Health 2024; 8: e506-e514.","DOI":"10.1016\/S2542-5196(24)00121-9"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s11684-020-0759-8","article-title":"Precision medicine in acute lymphoblastic leukemia","volume":"14","author":"Pui","year":"2020","unstructured":"Pui CH. Precision medicine in acute lymphoblastic leukemia. Front Med 2020; 14: 689-700.","journal-title":"Front Med"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Chang JH, Poppe MM, Hua CH, Marcus KJ and Esiashvili N. Acute lymphoblastic leukemia. Pediatr Blood Cancer 2021; 68 Suppl 2: e28371.","DOI":"10.1002\/pbc.28371"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10555-019-09834-0","article-title":"Immunotherapy in pediatric acute lymphoblastic leukemia","volume":"38","author":"Inaba","year":"2019","unstructured":"Inaba H and Pui CH. Immunotherapy in pediatric acute lymphoblastic leukemia. Cancer Metastasis Rev 2019; 38: 595-610.","journal-title":"Cancer Metastasis Rev"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s00277-023-05286-3","article-title":"Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia\/lymphoma","volume":"102","author":"Huang","year":"2023","unstructured":"Huang YH, Wan CL, Dai HP and Xue SL. Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia\/lymphoma. Ann Hematol 2023; 102: 2001-2013.","journal-title":"Ann Hematol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric acute lymphoblastic leukemia","volume":"105","author":"Inaba","year":"2020","unstructured":"Inaba H and Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica 2020; 105: 2524-2539.","journal-title":"Haematologica"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.3390\/ijms21124365","article-title":"Biological functions and therapeutic potential of lipocalin 2 in cancer","volume":"21","author":"Santiago-S&#xE1","year":"2020","unstructured":"Santiago-Sánchez GS, Pita-Grisanti V, Quiñones-Díaz B, Gumpper K, Cruz-Monserrate Z and Vivas-Mejía PE. Biological functions and therapeutic potential of lipocalin 2 in cancer. Int J Mol Sci 2020; 21: 4365.","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2005.10.027","article-title":"A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake","volume":"123","author":"Devireddy","year":"2005","unstructured":"Devireddy LR, Gazin C, Zhu X and Green MR. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 2005; 123: 1293-1305.","journal-title":"Cell"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"605777","DOI":"10.3389\/fonc.2020.605777","article-title":"LCN2 is a potential biomarker for radioresistance and recurrence in nasopharyngeal carcinoma","volume":"10","author":"Zhang","year":"2020","unstructured":"Zhang MX, Wang L, Zeng L and Tu ZW. LCN2 is a potential biomarker for radioresistance and recurrence in nasopharyngeal carcinoma. Front Oncol 2020; 10: 605777.","journal-title":"Front Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"7333","DOI":"10.1038\/s41467-021-27452-9","article-title":"A targetable LIFR-NF-κB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis","volume":"12","author":"Yao","year":"2021","unstructured":"Yao F, Deng Y, Zhao Y, Mei Y, Zhang Y, Liu X, Martinez C, Su X, Rosato RR, Teng H, Hang Q, Yap S, Chen D, Wang Y, Chen MM, Zhang M, Liang H, Xie D, Chen X, Zhu H, Chang JC, You MJ, Sun Y, Gan B and Ma L. A targetable LIFR-NF-κB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis. Nat Commun 2021; 12: 7333.","journal-title":"Nat Commun"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1007\/s11033-020-05261-5","article-title":"Implication and role of neutrophil gelatinase-associated lipocalin in cancer: lipocalin-2 as a potential novel emerging comprehensive therapeutic target for a variety of cancer types","volume":"47","author":"Rahimi","year":"2020","unstructured":"Rahimi S, Roushandeh AM, Ahmadzadeh E, Jahanian-Najafabadi A and Roudkenar MH. Implication and role of neutrophil gelatinase-associated lipocalin in cancer: lipocalin-2 as a potential novel emerging comprehensive therapeutic target for a variety of cancer types. Mol Biol Rep 2020; 47: 2327-2346.","journal-title":"Mol Biol Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"102129","DOI":"10.1016\/j.tranon.2024.102129","article-title":"GDF15 and LCN2 for early detection and prognosis of pancreatic cancer","volume":"50","author":"Zhu","year":"2024","unstructured":"Zhu X, Olson B, Keith D, Norgard MA, Levasseur PR, Diba P, Protzek S, Li J, Li X, Korzun T, Sattler AL, Buenafe AC, Grossberg AJ and Marks DL. GDF15 and LCN2 for early detection and prognosis of pancreatic cancer. Transl Oncol 2024; 50: 102129.","journal-title":"Transl Oncol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1002\/1878-0261.13484","article-title":"Osteoblast-derived extracellular vesicles exert osteoblastic and tumor-suppressive functions via SERPINA3 and LCN2 in prostate cancer","volume":"17","author":"Ito","year":"2023","unstructured":"Ito K, Yamamoto T, Hayashi Y, Sato S, Nakayama J, Urabe F, Shimasaki T, Nakamura E, Matui Y, Fujimoto H, Kimura T, Egawa S, Ochiya T and Yamamoto Y. Osteoblast-derived extracellular vesicles exert osteoblastic and tumor-suppressive functions via SERPINA3 and LCN2 in prostate cancer. Mol Oncol 2023; 17: 2147-2167.","journal-title":"Mol Oncol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/ijc.35205","article-title":"Sex- and site-specific associations of circulating lipocalin 2 and incident colorectal cancer: results from the EPIC cohort","volume":"156","author":"Reichmann","year":"2025","unstructured":"Reichmann R, Nimptsch K, Pischon T, Gunter MJ, Jenab M, Eriksen AK, Tjonneland A, Janke J, Katzke V, Kaaks R, Schulze MB, Eichelmann F, Masala G, Sieri S, Pasanisi F, Tumino R, Giraudo MT, Rothwell J, Severi G, Jakszyn P, Sanchez-Perez MJ, Amiano P, Colorado-Yohar SM, Guevara M, van Guelpen B, Aglago EK, Heath AK, Smith-Byrne K, Weiderpass E and Aleksandrova K. Sex- and site-specific associations of circulating lipocalin 2 and incident colorectal cancer: results from the EPIC cohort. Int J Cancer 2025; 156: 930-942.","journal-title":"Int J Cancer"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"6110","DOI":"10.1038\/onc.2008.209","article-title":"Lipocalin 2 is required for BCR-ABL-induced tumorigenesis","volume":"27","author":"Leng","year":"2008","unstructured":"Leng X, Lin H, Ding T, Wang Y, Wu Y, Klumpp S, Sun T, Zhou Y, Monaco P, Belmont J, Aderem A, Akira S, Strong R and Arlinghaus R. Lipocalin 2 is required for BCR-ABL-induced tumorigenesis. Oncogene 2008; 27: 6110-6119.","journal-title":"Oncogene"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1080\/10428190801942360","article-title":"Neutrophil gelatinase-associated lipocalin expression in chronic myeloid leukemia","volume":"49","author":"Villalva","year":"2008","unstructured":"Villalva C, Sorel N, Bonnet ML, Guilhot J, Mayeur-Rousse C, Guilhot F, Chomel JC and Turhan AG. Neutrophil gelatinase-associated lipocalin expression in chronic myeloid leukemia. Leuk Lymphoma 2008; 49: 984-988.","journal-title":"Leuk Lymphoma"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.18632\/oncotarget.1738","article-title":"Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer","volume":"5","author":"Candido","year":"2014","unstructured":"Candido S, Maestro R, Polesel J, Catania A, Maira F, Signorelli SS, McCubrey JA and Libra M. Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer. Oncotarget 2014; 5: 1576-1594.","journal-title":"Oncotarget"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3109\/10428194.2012.749402","article-title":"Higher lipocalin 2 expression may represent an independent favorable prognostic factor in cytogenetically normal acute myeloid leukemia","volume":"54","author":"Yang","year":"2013","unstructured":"Yang WC, Lin PM, Yang MY, Liu YC, Chang CS, Chou WC, Hsu JF, Huang CT, Cho SF, Yu WH and Lin SF. Higher lipocalin 2 expression may represent an independent favorable prognostic factor in cytogenetically normal acute myeloid leukemia. Leuk Lymphoma 2013; 54: 1614-1625.","journal-title":"Leuk Lymphoma"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1002\/1878-0261.13074","article-title":"Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion","volume":"15","author":"ES","year":"2021","unstructured":"Villodre ES, Hu X, Larson R, Finetti P, Gomez K, Balema W, Stecklein SR, Santiago-Sanchez G, Krishnamurthy S, Song J, Su X, Ueno NT, Tripathy D, Van Laere S, Bertucci F, Vivas-Mejía P, Woodward WA and Debeb BG. Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion. Mol Oncol 2021; 15: 2752-2765.","journal-title":"Mol Oncol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"116091","DOI":"10.1016\/j.biopha.2023.116091","article-title":"LCN2: Versatile players in breast cancer","volume":"171","author":"Bao","year":"2024","unstructured":"Bao Y, Yan Z, Shi N, Tian X, Li J, Li T, Cheng X and Lv J. LCN2: Versatile players in breast cancer. Biomed Pharmacother 2024; 171: 116091.","journal-title":"Biomed Pharmacother"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1113547","DOI":"10.3389\/fendo.2023.1113547","article-title":"The link between bone-derived factors osteocalcin, fibroblast growth factor 23, sclerostin, lipocalin 2 and tumor bone metastasis","volume":"14","author":"Martiniakova","year":"2023","unstructured":"Martiniakova M, Mondockova V, Biro R, Kovacova V, Babikova M, Zemanova N, Ciernikova S and Omelka R. The link between bone-derived factors osteocalcin, fibroblast growth factor 23, sclerostin, lipocalin 2 and tumor bone metastasis. Front Endocrinol (Lausanne) 2023; 14: 1113547.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jcrc.2019.07.001","article-title":"Performance of plasma measurement of neutrophil gelatinase-associated lipocalin as a biomarker of bacterial infections in the intensive care unit","volume":"53","author":"Jonsson","year":"2019","unstructured":"Jonsson N, Gille-Johnson P, Martling CR, Xu S, Venge P and Mårtensson J. Performance of plasma measurement of neutrophil gelatinase-associated lipocalin as a biomarker of bacterial infections in the intensive care unit. J Crit Care 2019; 53: 264-270.","journal-title":"J Crit Care"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Tan CD, van den Broek B, Womersley RS, Kaforou M, Hagedoorn NN, van der Flier M, Jackson H, Moll HA, Snijder R, de Jonge MI and Vermont CL; PERFORM Consortium. A novel combination of host protein biomarkers to distinguish bacterial from viral infections in febrile children in emergency care. Pediatr Infect Dis J 2023; 42: e235-e242.","DOI":"10.1097\/INF.0000000000003952"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Nielsen MJ, Baines P, Jennings R, Siner S, Kolamunnage-Dona R, Newland P, Peak M, Chesters C, Jeffers G, Downey C, Broughton C, McColl L, Preston J, McKeever A, Paulus S, Cunliffe N and Carrol ED. Procalcitonin, C-reactive protein, neutrophil gelatinase-associated lipocalin, resistin and the APTT waveform for the early diagnosis of serious bacterial infection and prediction of outcome in critically ill children. PLoS One 2021; 16: e0246027.","DOI":"10.1371\/journal.pone.0246027"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1200\/JCO.22.02734","article-title":"The clinicogenomic landscape of induction failure in childhood and young adult T-cell acute lymphoblastic leukemia","volume":"41","author":"O&#x2019","year":"2023","unstructured":"O’Connor D, Demeulemeester J, Conde L, Kirkwood A, Fung K, Papaleonidopoulou F, Bloye G, Farah N, Rahman S, Hancock J, Bateman C, Inglott S, Mee J, Herrero J, Van Loo P, Moorman AV, Vora A and Mansour MR. The clinicogenomic landscape of induction failure in childhood and young adult T-cell acute lymphoblastic leukemia. J Clin Oncol 2023; 41: 3545-3556.","journal-title":"J Clin Oncol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1038\/s41467-022-32266-4","article-title":"Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia","volume":"13","author":"Isobe","year":"2022","unstructured":"Isobe T, Takagi M, Sato-Otsubo A, Nishimura A, Nagae G, Yamagishi C, Tamura M, Tanaka Y, Asada S, Takeda R, Tsuchiya A, Wang X, Yoshida K, Nannya Y, Ueno H, Akazawa R, Kato I, Mikami T, Watanabe K, Sekiguchi M, Seki M, Kimura S, Hiwatari M, Kato M, Fukuda S, Tatsuno K, Tsutsumi S, Kanai A, Inaba T, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Kotecha RS, Cruickshank MN, Ishikawa F, Morio T, Eguchi M, Deguchi T, Kiyokawa N, Arakawa Y, Koh K, Aoki Y, Ishihara T, Tomizawa D, Miyamura T, Ishii E, Mizutani S, Wilson NK, Göttgens B, Miyano S, Kitamura T, Goyama S, Yokoyama A, Aburatani H, Ogawa S and Takita J. Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia. Nat Commun 2022; 13: 4501.","journal-title":"Nat Commun"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Winer H, Li W, Rodrigues G, Gower T, Meyer TJ, Hixon J and Durum SK. Mechanism of co-operation of mutant IL-7Rα and mutant NRAS in acute lymphoblastic leukemia: role of MYC. Haematologica 2024; 109: 1726-1740.","DOI":"10.3324\/haematol.2023.283559"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1080\/10428190701859664","article-title":"Requirement of lipocalin 2 for chronic myeloid leukemia","volume":"49","author":"Arlinghaus","year":"2008","unstructured":"Arlinghaus R and Leng X. Requirement of lipocalin 2 for chronic myeloid leukemia. Leuk Lymphoma 2008; 49: 600-603.","journal-title":"Leuk Lymphoma"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"132797","DOI":"10.1016\/j.ijbiomac.2024.132797","article-title":"Bioinformatics and experimental approach identify lipocalin 2 as a diagnostic and prognostic indicator for lung adenocarcinoma","volume":"272","author":"Li","year":"2024","unstructured":"Li A, Zhang K, Zhou J, Li M, Fan M, Gao H, Ma R, Gao L and Chen M. Bioinformatics and experimental approach identify lipocalin 2 as a diagnostic and prognostic indicator for lung adenocarcinoma. Int J Biol Macromol 2024; 272: 132797.","journal-title":"Int J Biol Macromol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1126\/science.aaz2193","article-title":"Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis","volume":"369","author":"Chi","year":"2020","unstructured":"Chi Y, Remsik J, Kiseliovas V, Derderian C, Sener U, Alghader M, Saadeh F, Nikishina K, Bale T, Iacobuzio-Donahue C, Thomas T, Pe’er D, Mazutis L and Boire A. Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis. Science 2020; 369: 276-282.","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41392-023-01478-5","article-title":"BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis","volume":"8","author":"Huang","year":"2023","unstructured":"Huang C, Li H, Xu Y, Xu C, Sun H, Li Z, Ge Y, Wang H, Zhao T, Gao S, Wang X, Yang S, Sun P, Liu Z, Liu J, Chang A and Hao J. BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis. Signal Transduct Target Ther 2023; 8: 271.","journal-title":"Signal Transduct Target Ther"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"100691","DOI":"10.1016\/j.mcpro.2023.100691","article-title":"Quantitative proteomics of tissue-infiltrating T cells from CRC patients identified lipocalin-2 induces T-cell apoptosis and promotes tumor cell proliferation by iron efflux","volume":"23","author":"Che","year":"2024","unstructured":"Che R, Wang Q, Li M, Shen J and Ji J. Quantitative proteomics of tissue-infiltrating T cells from CRC patients identified lipocalin-2 induces T-cell apoptosis and promotes tumor cell proliferation by iron efflux. Mol Cell Proteomics 2024; 23: 100691.","journal-title":"Mol Cell Proteomics"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/ijc.33711","article-title":"Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer","volume":"149","author":"Chaudhary","year":"2021","unstructured":"Chaudhary N, Choudhary BS, Shah SG, Khapare N, Dwivedi N, Gaikwad A, Joshi N, Raichanna J, Basu S, Gurjar M, P K S, Saklani A, Gera P, Ramadwar M, Patil P, Thorat R, Gota V, Dhar SK, Gupta S, Das M and Dalal SN. Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer. Int J Cancer 2021; 149: 1495-1511.","journal-title":"Int J Cancer"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/pros.24605","article-title":"Melittin inhibits tumor cell migration and enhances cisplatin sensitivity by suppressing IL-17 signaling pathway gene LCN2 in castration-resistant prostate cancer","volume":"83","author":"Yan","year":"2023","unstructured":"Yan R, Dai W, Mao Y, Yu G, Li W, Shu M and Xu B. Melittin inhibits tumor cell migration and enhances cisplatin sensitivity by suppressing IL-17 signaling pathway gene LCN2 in castration-resistant prostate cancer. Prostate 2023; 83: 1430-1445.","journal-title":"Prostate"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"109731","DOI":"10.1016\/j.cellsig.2020.109731","article-title":"Differential regulation of Lipocalin 2 (LCN2) in doxorubicin-resistant 4T1 triple negative breast cancer cells","volume":"74","author":"Meurer","year":"2020","unstructured":"Meurer SK, Tezcan O, Lammers T and Weiskirchen R. Differential regulation of Lipocalin 2 (LCN2) in doxorubicin-resistant 4T1 triple negative breast cancer cells. Cell Signal 2020; 74: 109731.","journal-title":"Cell Signal"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/s41419-019-2177-x","article-title":"Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3","volume":"10","author":"Huang","year":"2019","unstructured":"Huang Z, Zhang Y, Li H, Zhou Y, Zhang Q, Chen R, Jin T, Hu K, Li S, Wang Y, Chen W and Huang Z. Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3. Cell Death Dis 2019; 10: 936.","journal-title":"Cell Death Dis"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"617937","DOI":"10.3389\/fonc.2021.617937","article-title":"Overcoming glucocorticoid resistance in acute lymphoblastic leukemia: repurposed drugs can improve the protocol","volume":"11","author":"Olivas-Aguirre M","year":"2021","unstructured":"Olivas-Aguirre M, Torres-López L, Pottosin I and Dobrovinskaya O. Overcoming glucocorticoid resistance in acute lymphoblastic leukemia: repurposed drugs can improve the protocol. Front Oncol 2021; 11: 617937.","journal-title":"Front Oncol"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/4\/ajcr0160566.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:55:33Z","timestamp":1766022933000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/4\/ajcr0160566.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/asrb7620","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}